Go to page
 

Bibliographic Metadata

Title
Synergism between Hedgehog-GLI and EGFR signaling in hedgehog-responsive human medulloblastoma cells induces downregulation of canonical hedgehog-target genes and stabilized expression of GLI1
AuthorGötschel Reinhard Schwartz-Albiez,, Frank ; Berg, Daniela ; Gruber, Wolfgang ; Bender, Christian ; Eberl, Markus ; Friedel, Myriam ; Sonntag, Johanna ; Rüngeler, Elena ; Hache, Hendrik ; Wierling, Christoph ; Nietfeld, Wilfried ; Lehrach, Hans ; Frischauf, Annemarie ; Schwartz-Albiez, Reinhard ; Aberger, Fritz ; Korf, Ulrike
Published in
PLoS ONE, Lawrence, Kan., 2013, Vol. 8, page 1-12
PublishedPublic Library of Science, 2013
LanguageEnglish
Document typeJournal Article
Keywords (EN)Hedgehog signaling / EGFR signaling / Protein kinase signaling cascade / Signal inhibition / MAPK signaling cascades / Cell cultures / Gene expression / Protein expression
Project-/ReportnumberP20652
ISSN1932-6203
URNurn:nbn:at:at-ubs:3-2337 Persistent Identifier (URN)
DOI10.1371/journal.pone.0065403 
Restriction-Information
 The work is publicly available
Files
Synergism between Hedgehog-GLI and EGFR signaling in hedgehog-responsive human medulloblastoma cells induces downregulation of canonical hedgehog-target genes and stabilized expression of GLI1 [3.7 mb]
Links
Reference
Classification
Abstract (English)

Aberrant activation of Hedgehog (HH) signaling has been identified as a key etiologic factor in many human malignancies. Signal strength, target gene specificity, and oncogenic activity of HH signaling depend profoundly on interactions with other pathways, such as epidermal growth factor receptor-mediated signaling, which has been shown to cooperate with HH/GLI in basal cell carcinoma and pancreatic cancer. Our experimental data demonstrated that the Daoy human medulloblastoma cell line possesses a fully inducible endogenous HH pathway. Treatment of Daoy cells with Sonic HH or Smoothened agonist induced expression of GLI1 protein and simultaneously prevented the processing of GLI3 to its repressor form. To study interactions between HH- and EGF-induced signaling in greater detail, time-resolved measurements were carried out and analyzed at the transcriptomic and proteomic levels. The Daoy cells responded to the HH/EGF co-treatment by downregulating GLI1, PTCH, and HHIP at the transcript level; this was also observed when Amphiregulin (AREG) was used instead of EGF. We identified a novel crosstalk mechanism whereby EGFR signaling silences proteins acting as negative regulators of HH signaling, as AKT- and ERK-signaling independent process. EGFR/HH signaling maintained high GLI1 protein levels which contrasted the GLI1 downregulation on the transcript level. Conversely, a high-level synergism was also observed, due to a strong and significant upregulation of numerous canonical EGF-targets with putative tumor-promoting properties such as MMP7, VEGFA, and IL-8. In conclusion, synergistic effects between EGFR and HH signaling can selectively induce a switch from a canonical HH/GLI profile to a modulated specific target gene profile. This suggests that there are more wide-spread, yet context-dependent interactions, between HH/GLI and growth factor receptor signaling in human malignancies.

Stats
The PDF-Document has been downloaded 26 times.
License
CC-BY-License (4.0)Creative Commons Attribution 4.0 International License